Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01984554 · ClinicalTrials.gov registry record
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
A clinical trial, sponsored by American Regent.
- Completed
- Registry status
- 551
- Enrollment target
NCT01984554 is a clinical trial that has completed, run by American Regent. The registered enrollment target is 551 participants.
The verdict
NCT01984554 has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- 551 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01984554
The ClinicalTrials.gov registry entry for NCT01984554 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01984554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01984554 about?
NCT01984554 is a clinical study titled "Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia". The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
What is the current status of trial NCT01984554?
This trial is currently completed. The enrollment target is 551 participants. The study started on 2013-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01984554?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.